Driehaus Capital Management LLC

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 938206 Chicago, IL

Position in PRAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$305,830,802

+$30,820,403 QoQ

Shares Held

949,225

+1.7% QoQ

Ownership

3.40%

of shares outstanding

% of Portfolio

2.26%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 84.46321999525928.ToString("F0")% Shared 0.ToString("F0")% None 15.536780004740711.ToString("F0")%

Healthcare · as of Mar 31, 2026

Driehaus Capital Management LLC holds $3,010,622,183 across 56 Biotechnology names. PRAX ranks #1 (10.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc. This page	949,225	$305,830,802
2	XENE	Xenon Pharmaceuticals Inc.	4,491,653	$261,189,621
3	CRNX	Crinetics Pharmaceuticals, Inc.	6,395,922	$232,299,887
4	APGE	Apogee Therapeutics, Inc.	1,920,800	$161,673,736
5	EWTX	Edgewise Therapeutics, Inc.	4,477,942	$141,055,173
6	SYRE	Spyre Therapeutics, Inc.	2,790,785	$140,767,195
7	DFTX	Definium Therapeutics, Inc.	5,911,889	$111,734,702
8	SEPN	Septerna, Inc.	4,395,572	$105,625,595

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$305,830,802	949,225	+1.7%	Shares	Sole	2026-05-15
2025-12-31	$275,010,399	933,061	+86.4%	Shares	Sole	2026-02-17
2025-09-30	$26,529,203	500,551	-5.7%	Shares	Sole	2025-11-14
2025-06-30	$22,328,045	530,988	+10.3%	Shares	Sole	2025-08-14
2025-03-31	$18,238,116	481,598	+192.0%	Shares	Sole	2025-05-15
2024-12-31	$12,691,627	164,912	-0.7%	Shares	Sole	2025-02-14
2024-09-30	$9,554,862	166,056	-37.3%	Shares	Sole	2024-11-14
2024-06-30	$10,947,495	264,688	-0.7%	Shares	Sole	2024-08-15
2024-03-31	$16,261,585	266,496	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.